CD39 was utilized to detect tumor-specific T-cell clones in our ex-vivo experiments, which was capable of discriminating tumor-reactive T-cell clones from bystander clones such as virus-specific T cells from the tumor or periphery43,44. The gene discussed is ENTPD1; the disease is neoplasm.